REVLIMID Adverse Event: Myelodysplastic syndrome
REVLIMID Adverse Event: Myelodysplastic syndrome is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: REVLIMID; Product category: Drug; Primary reaction: Myelodysplastic syndrome.
| Primary drug | REVLIMID |
|---|---|
| Product category | Drug |
| Primary reaction | Myelodysplastic syndrome |
| All reactions | Myelodysplastic syndrome; Abasia; Chronic obstructive pulmonary disease; Diabetes mellitus; Pancytopenia |
| Seriousness | Serious |
| Patient outcome | Fatal |
| Patient sex | Female |
| All drugs reported | REVLIMID; HUMALOG; AMLODIPINE BESYLATE; FLUTICASONE PROPIONATE |
| Reporter country | US |
| Reporter type | 1 |
| Report date | 20140312 |
| Report ID | 10005078 |
$299/mo
Try FDATracker →